Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment

22 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35878684
DOI: 10.1016/j.jinf.2022.07.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatmentPMID 35878684Read ↗

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimabSemantic proximity Read ↗

Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxisSemantic proximity Read ↗

Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.Semantic proximity Read ↗

Genotypic and Predicted Phenotypic Analysis of SARS-CoV-2 Omicron Subvariants in Immunocompromised Patients with COVID-19 Following Tixagevimab-Cilgavimab ProphylaxisSemantic proximity Read ↗

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.Semantic proximity Read ↗

Therapeutics to tackle Omicron outbreak.Semantic proximity Read ↗

Features of the SARS-CoV-2 KP.3 variant mutations.Semantic proximity Read ↗

Sotrovimab drives SARS-CoV-2 Omicron variant evolution in immunocompromised patientsSemantic proximity Read ↗

Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, JapanSemantic proximity Read ↗

SARS-CoV-2 Omicron variant emerged under immune selectionSemantic proximity Read ↗

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Semantic proximity Read ↗

Omicron (B.1.1.529): constellation of unusual mutations in SARS-CoV-2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.